{"id":"W3203355818","doi":"10.1016/j.annonc.2021.08.094","title":"698P Analysis of hard-to-treat subgroups from EV-301: A phase III trial of enfortumab vedotin (EV) vs chemotherapy for previously treated advanced urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Internal medicine; Subgroup analysis; Cancer; Bladder cancer; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001871463,0.0009567195,0.001931939,0.000295455,0.0003304572,0.001176511,0.0006085284,0.001031296,0.004806387],"category_scores_gemma":[0.001924728,0.0003132041,0.0027016,0.0004036531,0.0006026266,0.0007811908,0.0004449755,0.002124069,0.0005367133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006071465,"about_ca_system_score_gemma":0.0008779023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000662628,"about_ca_topic_score_gemma":0.001966494,"domain_scores_codex":[0.9988638,0.0006479576,0.00005205286,0.0001709769,0.00009462599,0.0001706279],"domain_scores_gemma":[0.9990086,0.0004057491,0.0001498506,0.0001168228,0.00004844065,0.0002705858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9338267,0.003377887,0.00903412,0.0002959715,0.003621089,0.00009869798,0.00006565086,0.001449926,0.01143651,0.0002155532,0.002061888,0.03451597],"study_design_scores_gemma":[0.5562111,0.2991666,0.1126703,0.0001411079,0.008658277,0.0005593259,0.0002911828,0.006022463,0.006001152,0.002139312,0.008019661,0.0001195776],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951116,0.001040518,0.0003464236,0.0003442145,0.000128204,0.0003184156,0.001372961,0.00003080783,0.001306745],"genre_scores_gemma":[0.9935004,0.0004298772,0.0005281568,0.0004573739,0.0001146886,0.0003633619,0.002994553,0.0000271691,0.001584359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004806387,"threshold_uncertainty_score":0.01607901,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06765254941092885,"score_gpt":0.3978981944408646,"score_spread":0.3302456450299358,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}